How your organisation can help change the outlook for young people affected by a rare cancer
Many organisations are now deciding which cause to support in the coming year. The Harry Kazmi Foundation is inviting companies to choose it as their Charity of the Year for 2027, and has published a corporate partnership pack that sets out how a partnership could work.
Alveolar rhabdomyosarcoma is a rare and aggressive cancer that mainly affects children, teenagers and young adults. It is a serious disease, but few people know about it, and much more progress is needed in how it is diagnosed and treated. The Foundation is a registered charity in the UK. It works to improve the lives and future prospects of young people affected by the disease, bringing together science, research collaboration, education and advocacy.
For the Foundation, 2027 is a chance to build momentum. Work is under way on scientific knowledge, AI-enabled research intelligence and global collaboration, all aimed at a better understanding of alveolar rhabdomyosarcoma. A corporate partner’s support would help in five areas. The first is raising awareness of the symptoms so the cancer is recognised earlier. The second is research collaboration and knowledge sharing. The third is better diagnostic pathways and access to specialist expertise. The fourth is making sure young people and families affected by the disease are heard. The fifth is connecting scientists, clinicians, researchers and patients through the Foundation’s international memberships and partnerships.
The Foundation wants a partnership to benefit the company as well as the cause. A shared goal can bring colleagues together across a business. Challenges and events build relationships beyond day-to-day work. A partnership also gives a genuine, human story for CSR and ESG reporting, and shows colleagues, clients and job candidates the company’s values in action. Partners can get involved through employee fundraising and sponsored challenges, charity days and awareness talks, volunteering their professional skills, or sponsoring specific projects and campaigns.
The process is designed to be simple. It starts with an informal conversation about the company’s goals and culture. Together, the company and the Foundation then plan activities that fit its people and calendar. The partnership launches with the team, and the Foundation shares regular updates so everyone can see the difference they are making.
Every partnership, large or small, helps put a rare and often overlooked cancer in front of more people. It also helps move research forward and gives young people and their families a stronger voice. By choosing the Harry Kazmi Foundation as its Charity of the Year, a company becomes part of a growing mission to change the outlook for those affected by alveolar rhabdomyosarcoma. The partnership will be seen, felt and remembered long after 2027.
If you’d like to find out more about partnering with us, our brochure is a great place to start.
